Titan Pharmaceuticals, Inc.

Titan Pharmaceuticals, Inc.verified

TTNP

Price:

$2.34

Market Cap:

$6.93M

Titan Pharmaceuticals, Inc. is a pharmaceutical company dedicated to creating treatments for chronic conditions, with its product development centered around ProNeura, a unique platform designed for extended drug release. Currently, the company markets the Probuphine implant in Canada and the European Union. This implant provides maintenance treatment for clinically stable individuals struggling with opioid use disorder. Beyond Probuphine, Titan Pharmaceuticals is advancing several pipeline candidates. Among these is the kappa opioid agonist peptide program (TP-2021), which utilizes the ProNeura technology to address chronic pruritus. Another key development is a nalmefene implant program, a...[Read more]

Industry

Biotechnology

IPO Date

1996-01-18

Stock Exchange

NASDAQ

Ticker

TTNP

The PE Ratio as of June 2026 (TTM) for Titan Pharmaceuticals, Inc. (TTNP) is -0.80

According to Titan Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.80. This represents a change of -82.49% compared to the average of -4.58 of the last 4 quarters.

Titan Pharmaceuticals, Inc. (TTNP) Historical PE Ratio (quarterly & annually)

How has TTNP PE Ratio performed in the past?

The mean historical PE Ratio of Titan Pharmaceuticals, Inc. over the last ten years is 258.43. The current -0.80 PE Ratio has changed -131.01% with respect to the historical average. Over the past ten years (40 quarters), TTNP's PE Ratio was at its highest in in the September 2017 quarter at 2.96K. The PE Ratio was at its lowest in in the September 2020 quarter at -280.10.

Quarterly (TTM)
Annual

Average

258.43

Median

-0.00

Minimum

-370.72

Maximum

2.75K

Titan Pharmaceuticals, Inc. (TTNP) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Titan Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 150.18%

Maximum Annual PE Ratio = 2.75K

Minimum Annual Increase = -840.68%

Minimum Annual PE Ratio = -370.72

Quarterly (TTM)
Annual
YearPE RatioChange
20250.02-99.99%
2024209.42-92.37%
20232.75K-840.68%
2022-370.72150.18%
2021-0.25436.05%
2020-0.0513.24%
2019-0.00-92.62%
2018-0.00155.22%
2017-0.00-136.68%
20160.00-327.22%

Titan Pharmaceuticals, Inc. (TTNP) Average PE Ratio

How has TTNP PE Ratio performed in the past?

The current PE Ratio of Titan Pharmaceuticals, Inc. (TTNP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

985.10

5-year avg

516.86

10-year avg

258.43

Titan Pharmaceuticals, Inc. (TTNP) PE Ratio vs. Peers

How is TTNP’s PE Ratio compared to its peers?

Titan Pharmaceuticals, Inc.’s PE Ratio is less than Clearmind Medicine Inc. (-0.58), greater than Xenetic Biosciences, Inc. (-3.28), less than Soligenix, Inc. (-0.40), less than Ensysce Biosciences, Inc. (-0.15), greater than Kazia Therapeutics Limited (-2.83), greater than Can-Fite BioPharma Ltd. (-726.32), less than Qualigen Therapeutics, Inc. (-0.53), greater than Silo Pharma, Inc. (-1.25), less than Oragenics, Inc. (-0.27), less than CNS Pharmaceuticals, Inc. (-0.20),

Build a custom stock screener for Titan Pharmaceuticals, Inc. (TTNP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Titan Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Titan Pharmaceuticals, Inc. (TTNP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Titan Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Titan Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for Titan Pharmaceuticals, Inc. (TTNP)?

What is the highest PE Ratio for Titan Pharmaceuticals, Inc. (TTNP)?

What is the 3-year average PE Ratio for Titan Pharmaceuticals, Inc. (TTNP)?

What is the 5-year average PE Ratio for Titan Pharmaceuticals, Inc. (TTNP)?

How does the current PE Ratio for Titan Pharmaceuticals, Inc. (TTNP) compare to its historical average?